Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Holymed Pharma, officially known as Holymed (Beijing) Pharmaceutical Co., Ltd., is a Chinese pharmaceutical enterprise specializing in the development, manufacturing, and commercialization of high-quality medicinal products. The company's core business revolves around therapeutic areas such as cardiovascular, cerebrovascular, and digestive system diseases, as well as anti-infective treatments. Holymed operates state-of-the-art manufacturing facilities that adhere to international GMP standards, ensuring the production of safe and effective small molecule drugs. With a strong emphasis on research and development, the company continuously works on expanding its product portfolio through both internal innovation and generic drug consistency evaluations. Holymed serves a broad patient base within China through an extensive marketing and distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Holymed Pharma.